Brain Edema: Clinical Trials

18 trials for Brain Edema, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 4 withdrawn, 3 terminated, 2 recruiting. 18 Phase 2, 4 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 218Completed 6, Withdrawn 4, Terminated 3, Recruiting 2, Active not recruiting 1, Not yet recruiting 1, Unknown 1
Phase 14Terminated 2, Completed 1, Withdrawn 1
Phase 31Completed 1

Follow Brain Edema: new trials by email Literature Review of Brain Edema trials Research Report on Brain Edema

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Prophylactic Versus Late Salvage Recombinant Human Endostatin in Managing Radiosurgery-Induced Brain Injury for NSCLC Brain Metastases
Recombinant Human Endostatin (Endostar) - Lung Cancer (Non-Small Cell), Radiation
Phase 2Not yet recruitingJiangmen Central Hospital492026-09-012026-10-01
Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema
Salovum/SPC flakes - Glioblastoma, Cerebral Metastases
Phase 2RecruitingPeter Siesjö202024-01-272025-01-27
Safety and Efficacy of ABX-101 in Participants Aged 18 to 50 Years of Age With Moderate to Severe Traumatic Brain Injury
ABX-101 1mg, ABX-101 2mg - Traumatic Brain Injury, Cerebral Edema
Phase 2UnknownAbalonex, LLC452023-12-012023-10-23
A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction
HRS8179, Placebo - Brain Swelling, Large Hemispheric Infarction
Phase 2CompletedBeijing Suncadia Pharmaceuticals Co., Ltd402023-04-072025-01-06
Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)
MW189, Saline - Intracerebral Hemorrhage
Phase 2Active not recruitingJohns Hopkins University1202022-10-102026-04-02
Antisecretory Factor In Severe Traumatic Brain Injury
Salovum, Placebo egg yolk powder - Traumatic Brain Injury
Phase 2RecruitingPeter Siesjö202020-03-102026-01-21
Antisecretory Factor in Primary Glioblastoma 1
Salovum - Glioblastoma, Cerebral Edema
Phase 1 / Phase 2CompletedPeter Siesjö82019-09-012021-04-28
Anti-secretory Factor as a Treatment for Adults With Severe Traumatic Head Injury
Salovum - Head Trauma, Intensive Care Neurological Disorder
Phase 2WithdrawnPeter Siesjö2018-03-012018-12-12
Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral Embolism
Glibenclamide, Placebo - Acute Stroke
Phase 2 / Phase 3CompletedNanfang Hospital, Southern Medical University3062018-01-012023-06-12
Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)
Glyburide, Placebo - Cerebral Edema, Brain Metastases
Phase 1 / Phase 2TerminatedUniversity of Alabama at Birmingham12017-08-162022-09-21
Safety & Tolerability of Hypertonic Saline Administration Via Intraosseous Access
Intraosseous, Hypertonic saline - Stroke, Intracranial Hypotension
Phase 2CompletedOhio State University62017-04-212019-07-09
Sevoflurane in Subarachnoidal Haemorrhage
Sevoflurane, Propofol, Midazolam - Subarachnoid Haemorrhage (SAH)
Phase 2WithdrawnUniversity of Zurich2015-11-012020-06-02
Study of Stroke Related Edema Treatments
Conivaptan, Hypertonic saline, Mannitol - Acute Cerebrovascular Accident, Cerebral Edema
Phase 2WithdrawnUniversity of Florida2015-09-012016-12-14
Histamine Glutamate Antagonism in Stroke
Diphenhydramine, Pantoprazole, Famotidine - Acute Cerebrovascular Accident, Cerebral Edema
Phase 2CompletedUniversity of Florida32014-12-012015-12-15
Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury
Induced, sustained hypernatremia using hypertonic saline, Standard of care (hypertonic saline and mannitol; serum sodium) - Traumatic Brain Injury, Subdural Hematoma
Phase 1 / Phase 2WithdrawnMassachusetts General Hospital2012-07-012016-12-12
Tolerability Study of Xerecept® in Pediatric Patients
XERECEPT - Brain Edema, Brain Tumor
Phase 1 / Phase 2TerminatedCeltic Pharma Development Services152010-06-012013-07-30
Pilot Study For Hypothermia Treatment In Hyperammonemic Encephalopathy In Neonates And Very Young Infants
Therapeutic Hypothermia, Standard of Care Therapy - Urea Cycle Disorders, Organic Acidemias
Phase 2CompletedUta Lichter-Konecki52007-08-012015-06-01
Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme
Boswellia serrata extract, cyanocobalamin - Brain and Central Nervous System Tumors, Cerebral Edema
Phase 2TerminatedAli Altunkaya122004-09-012019-04-30

Narrower conditions

Brain Injuries, Traumatic (4)  ·  Stroke (4)  ·  Glioblastoma (3)  ·  Brain Diseases (2)  ·  Brain Injuries (2)  ·  Brain Neoplasms (2)  ·  Craniocerebral Trauma (2)  ·  Ischemic Stroke (2)  ·  Argininosuccinic Aciduria (1)  ·  Astrocytoma (1)  ·  Brain Contusion (1)  ·  Carbamoyl-Phosphate Synthase I Deficiency Disease (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Central Nervous System Diseases (1)

Broader conditions

Central Nervous System Diseases (17)  ·  Nervous System Diseases (17)  ·  Brain Diseases (16)  ·  Cardiovascular Diseases (7)  ·  Cerebrovascular Disorders (7)  ·  Vascular Diseases (7)  ·  Neoplasms (6)  ·  Neoplasms by Site (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Trauma, Nervous System (5)  ·  Nervous System Neoplasms (4)  ·  Pathologic Processes (4)  ·  Wounds and Injuries (4)  ·  Brain Injuries (3)  ·  Central Nervous System Neoplasms (3)

Interventions

Saline Solution, Hypertonic (3)  ·  Glyburide (2)  ·  Mannitol (2)  ·  Sodium Chloride (2)  ·  antisecretory factor (2)  ·  Acetazolamide (1)  ·  Continuous Renal Replacement Therapy (1)  ·  Cool-Down Exercise (1)  ·  Corticotropin-Releasing Hormone (1)  ·  Cryotherapy (1)  ·  Dextromethorphan (1)  ·  Dialysis (1)  ·  Diphenhydramine (1)  ·  Endostatins (1)  ·  Famotidine (1)

Sponsors

Peter Siesjö (4)  ·  University of Florida (2)  ·  Abalonex, LLC (1)  ·  Ali Altunkaya (1)  ·  Beijing Suncadia Pharmaceuticals Co., Ltd (1)  ·  Celtic Pharma Development Services (1)  ·  Jiangmen Central Hospital (1)  ·  Johns Hopkins University (1)  ·  Massachusetts General Hospital (1)  ·  Nanfang Hospital, Southern Medical University (1)  ·  Ohio State University (1)  ·  University of Alabama at Birmingham (1)  ·  University of Zurich (1)  ·  Uta Lichter-Konecki (1)

Countries

United States (7)  ·  Sweden (3)  ·  China (2)  ·  Switzerland (1)

Top investigators

Brian P Walcott, MD (1)  ·  Brian V Nahed, MD (1)  ·  David Cederberg, Consultant (1)  ·  Emanuela Keller, MD Prof. (1)  ·  Glen Stevens, DO, PhD (1)  ·  Linda Van Eldik (1)  ·  Michael F Waters, MD (1)  ·  Sameer A Sheth, MD PhD (1)  ·  Stewart Goldman, MD (1)  ·  Suyue Pan, M.D., Ph.D. (1)  ·  Uta Lichter-Konecki, MD, PhD (1)  ·  Vishnumurthy S Hedna, MD (1)  ·  Vishnumurthy Shushuthra Hedna, MD (1)

Results publications

PMID 32527232, PMID 36803465, PMID 37919545, PMID 37965431, PMID 39920739, PMID 40236420, PMID 41040632

NIH funding

2019 (1), R01AG069930 (1), R21CA107277 (1)